Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Conmed (CNMD) Deferred Taxes (2016 - 2026)

Conmed filings provide 17 years of Deferred Taxes readings, the most recent being $1.5 million for Q1 2026.

On a quarterly basis, Deferred Taxes rose 157.73% to $1.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $7.7 million, a 0.51% increase, with the full-year FY2025 number at $3.5 million, down 71.13% from a year prior.
Deferred Taxes hit $1.5 million in Q1 2026 for Conmed, up from $812000.0 in the prior quarter.
In the past five years, Deferred Taxes ranged from a high of $70.2 million in Q2 2022 to a low of -$44.5 million in Q4 2022.
Median Deferred Taxes over the past 5 years was $1.2 million (2024), compared with a mean of $701058.8.
The widest YoY moves for Deferred Taxes: up 7642.56% in 2022, down 6900.0% in 2022.
Conmed's Deferred Taxes stood at -$44.5 million in 2022, then surged by 103.58% to $1.6 million in 2023, then skyrocketed by 313.32% to $6.6 million in 2024, then plummeted by 87.65% to $812000.0 in 2025, then soared by 89.04% to $1.5 million in 2026.
The last three reported values for Deferred Taxes were $1.5 million (Q1 2026), $812000.0 (Q4 2025), and $3.7 million (Q3 2025) per Business Quant data.